Renal function and outcome after continuous flow left ventricular assist device implantation

Area of Science:

• Cardiology
• Nephrology
• Medical Devices

Background:

• The role of renal dysfunction as a risk factor in patients undergoing left ventricular assist device (LVAD) implantation remains debated.
• This study investigates the impact of pre-existing renal function on outcomes following continuous-flow LVAD implantation.

Purpose of the Study:

• To determine the effect of renal function on patient outcomes after continuous flow LVAD implantation.
• To assess the potential for renal function improvement with LVAD support.

Main Methods:

• Retrospective analysis of 86 advanced heart failure patients who received continuous flow LVADs as a bridge to transplantation.
• Renal function was assessed using Modification of Diet in Renal Disease (MDRD) study-derived glomerular filtration rates (GFR).
• Patients were stratified into two groups: normal renal function (GFR > 60) and renal dysfunction (GFR < 60).

Main Results:

• Patients with pre-LVAD renal dysfunction (GFR < 60) exhibited significantly lower 6-month survival rates compared to those with normal renal function (47.9% vs. 72.6%, p=0.038).
• The bridge-to-transplant rate was lower in patients with renal dysfunction (40.0% vs. 63.0%, p=0.033).
• Renal function improved significantly in patients with pre-LVAD renal dysfunction after LVAD implantation (GFR increased from 41.7 to 62.7, p=0.021).
• Recovery of renal function post-LVAD was associated with improved survival (p < 0.001).

Conclusions:

• Renal dysfunction is associated with poorer outcomes after continuous flow LVAD implantation.
• LVAD support can lead to improvement in renal function and is linked to enhanced post-implantation survival.
• Pre-operative renal function is a critical factor in patient selection for LVAD therapy.